Search Results

Saved Studies

Your search for Oncology (Pediatrics) | All Regions returned 13 studies.

 
Active, currently enrolling    Who can join   

A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)

Keywords: Glioma; Neurofibromatoses; Neurofibromatosis 1; Neurofibroma; Neoplasms;…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Active, currently enrolling    Who can join   

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

Keywords: Oncology (Pediatrics); Oncology…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Active, currently enrolling    Who can join   

LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)

Keywords: Lung Neoplasms; Carcinoma; Non-Small-Cell Lung; Respiratory Tract Neoplasms;…
Study Type: INTERVENTIONAL   |  Region: Colorado

Enrollment complete    Who can join   

A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma

Keywords: Sarcoma; Sarcoma; Ewing; Neuroectodermal Tumors; Neuroectodermal Tumors;…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Enrollment complete    Who can join   

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms Tumor

Keywords: Oncology (Pediatrics); Oncology (Adult); COG-AREN0532; NCI; National Cancer…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Enrollment complete    Who can join   

A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)

Keywords: Lymphoma; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia;…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Enrollment complete    Who can join   

Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Keywords: Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Lymphoid;…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Enrollment complete    Who can join   

Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Keywords: Neoplasms, Sarcoma, Sarcoma, Ewing, Neuroectodermal Tumors, Neuroectodermal…
Study Type: INTERVENTIONAL   |  Region: California - Northern

Active, currently enrolling    Who can join   

Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer

Keywords: Hematology;Oncology (Pediatrics);
Study Type: INTERVENTIONAL   |  Region: California - Northern

12